Momentum in Pet Business: A Catalyst for CL's Growth Phase?

Colgate-Palmolive is focused on expanding its pet care business, Hill's Pet Nutrition, to capture a larger share of the growing pet market, including expansion into fresh pet food and the recent acquisition of Prime100 pet food brand. Hill's Pet Nutrition contributed $1.1 billion, or 23%, to Colgate's Q1 2025 sales, with expectations of 1.3% growth in 2025, as the company competes with Tractor Supply, Chewy, and Central Garden & Pet. Despite a year-to-date stock gain of 2.6%, Colgate's forward price-to-earnings ratio is 24.40X, higher than the industry average, with EPS expected to grow 1.4% and 7.3% in 2025 and 2026, respectively.

Analysis

Colgate-Palmolive is strategically emphasizing its Hill's Pet Nutrition division as a key growth engine, capitalizing on the expanding pet care market and rising consumer demand for premium, science-led pet products. This segment contributed a significant $1.1 billion, representing approximately 23% of total company sales in first-quarter 2025, and is being further bolstered by initiatives such as the planned entry into the fresh pet food market and the February agreement to acquire Care TopCo Pty Ltd, owner of the Prime100 pet food brand. While the Pet Nutrition segment is projected for a 1.3% year-over-year sales growth in 2025, the company's overall EPS is expected to grow 1.4% in 2025 and a more substantial 7.3% in 2026, with the 2026 estimate having been revised upwards in the past 30 days. Colgate's shares have gained 2.6% year-to-date, outperforming the industry's 0.7% growth, though the stock trades at a premium forward price-to-earnings ratio of 24.40X compared to the industry average of 20.77X. The company faces robust competition from players like Tractor Supply, Chewy, and Central Garden & Pet, each employing distinct strategies within the pet care sector.

Key Decisions for Investors

• Investors should acknowledge Colgate-Palmolive's strategic focus on the high-growth pet nutrition sector through its Hill's division as a positive long-term catalyst, supported by recent acquisitions and product line expansions.
• Carefully weigh the current premium valuation, reflected in a forward P/E of 24.40X, against the projected EPS growth of 1.4% for 2025 and the modest 1.3% sales growth forecast for the Pet Nutrition segment in the same year, while noting the more encouraging 7.3% EPS growth expected for 2026.
• Monitor the company's ability to successfully integrate acquisitions like Prime100, accelerate sales growth within the Pet Nutrition segment beyond current forecasts, and effectively navigate the competitive landscape to sustain its valuation and achieve earnings targets, particularly the upwardly revised 2026 estimates.